Gene · 249
Papers3,295
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,295
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A). | Stem Cell Res | 2022 | 36152425 | PubTator, text mining | PubMed |
| Mesoporous Bioactive Glasses Incorporated into an Injectable Thermosensitive Hydrogel for Sustained Co-Release of Sr2+ Ions and N-Acetylcysteine. | Pharmaceutics | 2022 | 36145638 | PubTator, text mining | PubMed |
| 3D-Printing Graphene Scaffolds for Bone Tissue Engineering. | Pharmaceutics | 2022 | 36145582 | PubTator, text mining | PubMed |
| Enzyme-Triggered Crosslinked Hybrid Hydrogels for Bone Tissue Engineering. | Materials (Basel) | 2022 | 36143697 | PubTator, text mining | PubMed |
| Real and Simulated Microgravity: Focus on Mammalian Extracellular Matrix. | Life (Basel) | 2022 | 36143379 | PubTator, text mining | PubMed |
| Human Primary Odontoblast-like Cell Cultures-A Focused Review Regarding Cell Characterization. | J Clin Med | 2022 | 36142943 | PubTator, text mining | PubMed |
| Gene Expression and Chondrogenic Potential of Cartilage Cells: Osteoarthritis Grade Differences. | Int J Mol Sci | 2022 | 36142513 | PubTator, text mining | PubMed |
| Trends and Perspectives of Biological Drug Approvals by the FDA: A Review from 2015 to 2021. | Biomedicines | 2022 | 36140426 | PubTator, text mining | PubMed |
| RNAa-mediated epigenetic attenuation of the cell senescence via locus specific induction of endogenous SIRT1. | Sci Rep | 2022 | 36138054 | PubTator, text mining | PubMed |
| Systematic review on the application of 3D-bioprinting technology in orthoregeneration: current achievements and open challenges. | J Exp Orthop | 2022 | 36121526 | PubTator, text mining | PubMed |
| Enhancer RNA commits osteogenesis via microRNA-3129 expression in human bone marrow-derived mesenchymal stem cells. | Inflamm Regen | 2022 | 36114571 | PubTator, text mining | PubMed |
| Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones. | Mol Metab | 2022 | 36103974 | PubTator, text mining | PubMed |
| Dental manifestations in adult hypophosphatasia and their correlation with biomarkers. | JIMD Rep | 2022 | 36101824 | PubTator, text mining | PubMed |
| Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance. | Cell Death Discov | 2022 | 36100611 | PubTator, text mining | PubMed |
| Impact of discontinuing 5 years of enzyme replacement treatment in a cohort of 6 adults with hypophosphatasia: A case series. | Bone Rep | 2022 | 36097602 | PubTator, text mining | PubMed |
| Effects of HSD11B1 knockout and overexpression on local cortisol production and differentiation of mesenchymal stem cells. | Front Bioeng Biotechnol | 2022 | 36091434 | PubTator, text mining | PubMed |
| Identifying interpretable gene-biomarker associations with functionally informed kernel-based tests in 190,000 exomes. | Nat Commun | 2022 | 36088354 | PubTator, text mining | PubMed |
| Quassinoids from Eurycoma longifolia and their bone formation evaluation in zebrafish, C3H10 cells and silico. | Chem Biol Interact | 2022 | 36087817 | PubTator, text mining | PubMed |
| Silymarin prevents iron overload induced bone loss by inhibiting oxidative stress in an ovariectomized animal model. | Chem Biol Interact | 2022 | 36087815 | PubTator, text mining | PubMed |
| The Strong Protective Action of Ce3+/F- Combined Treatment on Tooth Enamel and Epithelial Cells. | Nanomaterials (Basel) | 2022 | 36080071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/249/papers?page=38